Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) Net Margin (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Net Margin for 8 consecutive years, with 19.59% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin fell 259.0% to 19.59% in Q4 2025 year-over-year; TTM through Dec 2025 was 19.44%, a 1785.0% decrease, with the full-year FY2025 number at 1.78%, down 19.0% from a year prior.
  • Net Margin was 19.59% for Q4 2025 at Select Medical Holdings, up from 20.37% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 102.12% in Q4 2023 to a low of 20.37% in Q3 2025.
  • A 5-year average of 8.13% and a median of 3.09% in 2024 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: skyrocketed 9496bps in 2022, then crashed -11912bps in 2024.
  • Select Medical Holdings' Net Margin stood at 4.25% in 2021, then skyrocketed by 2234bps to 99.21% in 2022, then rose by 3bps to 102.12% in 2023, then plummeted by -117bps to 17.0% in 2024, then decreased by -15bps to 19.59% in 2025.
  • Per Business Quant, the three most recent readings for SEM's Net Margin are 19.59% (Q4 2025), 20.37% (Q3 2025), and 19.85% (Q2 2025).